1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. InMode Ltd.
  6. Summary
    INMD   IL0011595993

INMODE LTD.

(INMD)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
23.35 USD   -1.77%
05/03Needham Adjusts InMode's Price Target to $58 From $82 on 'Peer Multiple Compression,' Reiterates Buy Rating
MT
05/02SECTOR UPDATE : Health Care Stocks Largely Sit Out Afternoon Recovery
MT
05/02SECTOR UPDATE : Health Care Stocks Sinking with Broader Monday Markets
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
22.99(c) 23.77(c) 23.02(c) 23.77(c) 23.35(c) Last
1 705 118 1 984 488 1 341 223 2 074 693 1 234 806 Volume
-5.47% +3.39% -3.16% +3.26% -1.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 417 M - -
Net income 2022 166 M - -
Net Debt 2022 - - -
P/E ratio 2022 12,1x
Yield 2022 -
Sales 2023 463 M - -
Net income 2023 195 M - -
Net Debt 2023 - - -
P/E ratio 2023 10,7x
Yield 2023 -
Capitalization 1 940 M 1 940 M -
Capi. / Sales 2022 4,65x
Capi. / Sales 2023 4,19x
Nbr of Employees 362
Free-Float 82,5%
More Financials
Company
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin... 
More about the company
Ratings of InMode Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about INMODE LTD.
05/03Needham Adjusts InMode's Price Target to $58 From $82 on 'Peer Multiple Compression,' R..
MT
05/02SECTOR UPDATE : Health Care Stocks Largely Sit Out Afternoon Recovery
MT
05/02SECTOR UPDATE : Health Care Stocks Sinking with Broader Monday Markets
MT
05/02Earnings Flash (INMD) INMODE Reports Q1 EPS $0.40, vs. Street Est of $0.38
MT
05/02Earnings Flash (INMD) INMODE Posts Q1 Revenue $85.9M, vs. Street Est of $83.5M
MT
05/02InMode Posts Higher Q1 Earnings, Sales
MT
05/02TRANSCRIPT : InMode Ltd., Q1 2022 Earnings Call, May 02, 2022
CI
05/02INMODE : Q1 Earnings Snapshot
AQ
05/02InMode Ltd. Provides Earnings Guidance for the Full Year Ending Dec. 31, 2022
CI
04/11InMode Provides Q1 Non-GAAP Earnings, Revenue Guidance
MT
04/11InMode Ltd. Provides Revenue Guidance for the First Quarter Ended March 31, 2022
CI
03/17TRANSCRIPT : InMode Ltd. Presents at Barclays Global Healthcare Conference 2022, Mar-17-20..
CI
03/10InMode's Board Approves Share Buyback Plan
MT
03/10InMode Announces Share Repurchase Program of Up to 1 Million Shares
PR
03/10InMode Ltd. announces an Equity Buyback for 1,000,000 shares.
CI
More news
News in other languages on INMODE LTD.
05/02MISE À JOUR SECTORIELLE : Les actions du secteur de la santé chutent avec les marchés plus..
05/02Earnings Flash (INMD) INMODE affiche un chiffre d'affaires de 85,9 millions de dollars ..
05/02InMode affiche des bénéfices et des ventes plus élevés au 1er trimestre
05/02InMode Ltd. fournit des prévisions de bénéfices pour l'année complète se terminant le 3..
04/11InMode fournit des prévisions de revenus et de bénéfices non GAAP pour le premier trime..
More news
Analyst Recommendations on INMODE LTD.
More recommendations
Stock Trading Strategies
INMODE LTD. - 2021
Towards the breakout of a major resistance level
BUY
More Stock Trading Analysis
Chart INMODE LTD.
Duration : Period :
InMode Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INMODE LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 23,35 $
Average target price 55,50 $
Spread / Average Target 138%
EPS Revisions
Managers and Directors
Moshe Mizrahy Chairman & Chief Executive Officer
Yair Malca Chief Financial Officer
Michael Kreindel Chief Technology Officer & Director
Spero Theodorou Chief Medical Officer
Hadar Resnekov-Ron Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INMODE LTD.-66.92%1 940
THERMO FISHER SCIENTIFIC-17.46%217 320
DANAHER CORPORATION-23.47%180 262
INTUITIVE SURGICAL, INC.-39.03%78 637
SIEMENS HEALTHINEERS AG-16.99%64 649
EDWARDS LIFESCIENCES CORPORATION-27.19%58 644